Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 36,133 | $0.22 | $7,949 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Tax Withholding | 2024-11-04 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 6,104 | $2.09 | 36,133 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 17,000 | $0 | 36,133 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 13,666 | $0 | 52,571 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 4,218 | $5.12 | 52,571 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 17,000 | $0 | 32,789 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 5,676 | $2.22 | 32,789 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-04 6:55 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 623 | $2.58 | 10,465 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 6:55 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 2,000 | $0 | 10,465 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:27 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:39 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:04 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 14,115 | $1.12 | 30,885 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:08 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 380,000 | $0 | 380,000 (Direct) | View |
Ownership | 2021-06-10 5:23 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer | 0 | $0 | 407,832 (Direct) | View |